Last update: Sept. 19, 2016


Very Low Risk for breastfeeding

Safe. Compatible.
Not risky for breastfeeding or infant.

Antiamoebic agent with intraluminal action.

At latest update no published data were found regarding breastfeeding.

Its low intestinal absorption makes it highly unlikely the passage of significant amounts into breast milk as well as it would not be absorbed by the infant intestine.


We do not have alternatives for Quinfamide since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Quinfamide in other languages or writings:


Quinfamide belongs to this group or family:


Main tradenames from several countries containing Quinfamide in its composition:


Variable Value Unit
Oral Bioavail. Baja - Poor %
Molecular weight 354 daltons


  1. ROMERO-CABELLO, RAÚL et al. Evaluation of the efficacy and security of quinfamide administered in a single dose of 300 mg in adult patients with intestinal amebiasis. Parasitol. latinoam. 2005, vol.60, n.1-2, pp.57-60. 2005 Full text (link to original source) Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at

e-lactancia is a resource recommended by La Liga de la Leche de Euskadi

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM